Article
In vivo induction of tolerance by an Ig peptide is not affected by the deletion of FcR or a mutated IgG Fc fragment.
International immunology - 1 Jul 2002
el-Amine Moustapha, Hinshaw Jennifer A, Scott David W
Abstract excerpt
To induce tolerance to a variety of epitopes, we have designed a gene therapy approach in which peptides or antigens are expressed in frame on a soluble IgG fusion protein scaffold and delivered via retroviral gene therapy in B cells in vivo. Initially, tolerance to the lambda repressor cI sequence p1-102 or its immunodominant epitopes (e.g. p12-26 or p73-88) was elicited in both T cells and B cells when...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
